What is VRTX's current stock price?

As of now, VRTX is trading at $419.13, with a daily change of -3.76%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

VRTX Stock Analysis & IQ Rating | Vertex Pharma

VRTX

Vertex Pharma

$419.13

-$16.39 | -3.76%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$519.68

MKT CAP

$106.63B

52W Low

$362.5

VOL

$783.47K

P/E Ratio

29.49

AVG VOL

$1.34M

RSI

48.58

TREND

Sideways

VRTX Stock IQ

Login to see Vertex Pharma (VRTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

VRTX Target Price

Login to display

Strengths

VRTX Rewards

Earnings are forecast to grow

VRTX Rewards

Upgraded on attractively valued

VRTX Rewards

Outperform the market

VRTX Rewards

Investors confidence is positive

Chart

$426.27 (-1.67%)

$388.94 (+7.76%)

$441.3 (-5.02%)

$465.73 (-10.01%)

1year

6month

3month

1month

VRTX Risk Level

VRTX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

VRTX Analysts Opinion

VRTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

VRTX Analysts Opinion

VRTX Analysts opinion is positive and also has improved from the past 3 months

VRTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

66%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

25%

92%

VRTX Street Sentiment

VRTX Street Sentiment is bullish and have positive views on the near-term outlook

VRTX Performance Sentiment

Sentiments overview associated with VRTX events and the stock performance.

66%

20%

Positive

Negative

27 out of 41
events present

8 out of 41
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$437.15

Resistance
Price

$405.58

Current Price Range

$444.70

Show methods +

VRTX Latest Analysis +

Stifel Maintains Hold Rating on Vertex (VRTX) Keeps $445 Price Target. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best gene-editing stocks to buy according to hedge funds. On November 10 Stifel maintained a Hold rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). The firm also kept its price target at $445 for the stock. Stifels analysts referenced Vertexs presentation of povetacicept (a dual BAFF/APRIL inhibitor) open-label Phase [….]

Tue Nov 18, 2025

$435.52 | +0.35%

Potential

Goldman Sachs Remains ish on Vertex (VERX) After Q3 2025 Results. Vertex Inc. (NASDAQ:VERX) is included in our list of the overlooked tech stocks to invest in. Vertex Inc. (NASDAQ:VERX) experienced a price target cut on November 5 2025 with Goldman Sachs lowering its target from $43 to $28 while reiterating a Buy rating. The price revision reflects short-term headwinds such as customer bankruptcies and rapid [….]

Mon Nov 17, 2025

$434.02 | -0.72%

Potential

1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November. Key PointsVertexs core business continues to drive strong financial results.

Mon Nov 17, 2025

$434.02 | -0.72%

Earnings

Vertex Resource Group Ltd. Reports Third Quarter 2025 Results. ) - Vertex Resource Group Ltd. (".". or the ".Company".) reports its financial and operational results for the third quarter ended . During the third quarter tariff uncertainties and trade fluctuations persisted maintaining the external pressures that have been the theme throughout the year. In addition customer consolidation further curtailed spending while increasing pricing competitiveness for upcoming projects. Des

Thu Nov 13, 2025

$434.52 | +0.08%

Activity

Potential

V2X INC. ANNOUNCES SALE OF 2.25 MILLION SHARES OF COMMON STOCK IN SECONDARY OFFERING BY VERTEX AEROSPACE. RESTON Va. Nov. 12 2025 /PRNewswire/ -- V2X Inc. (NYSE:VVX) (V2X) a leading provider of global mission solutions announced today the sale of 2.25 million shares of its common stock on an underwritten basis by Vertex Aerospace Holdco LLC (Vertex Aerospace). V2X is not selling any...

Wed Nov 12, 2025

$434.19 | +1.16%

Activity

Vertex Pharmaceuticals Incorporated (VRTX) Presents at UBS Global Healthcare Conference 2025 Transcript.

Tue Nov 11, 2025

$429.22 | +1.93%

Activity

Agree To Buy Vertex Pharmaceuticals At $290 Earn 6.5% Using Options. Investors considering a purchase of Vertex Pharmaceuticals Inc. (Symbol: VRTX) shares but cautious about paying the going market price of $416.38/share might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contrac

Thu Nov 6, 2025

$416.25 | -0.18%

Activity

Potential

Goldman Sachs Maintains Vertex (VERX) Buy Recommendation. Fintel reports that on November 5 2025 Goldman Sachs maintained coverage of Vertex (NasdaqGM:VERX) with a Buy recommendation. Analyst Price Forecast Suggests 89.34% Upside

Thu Nov 6, 2025

$416.25 | -0.18%

Rating

Vertex price target lowered to $24 from $34 at BofA.

Wed Nov 5, 2025

$417.00 | -1.11%

Potential

RBC Capital Maintains Vertex Pharmaceuticals (VRTX) Sector Perform Recommendation. Fintel reports that on November 4 2025 RBC Capital maintained coverage of Vertex Pharmaceuticals (NasdaqGS:VRTX) with a Sector Perform recommendation. Analyst Price Forecast Suggests 16.61% Upside

Wed Nov 5, 2025

$417.00 | -1.11%

Potential

FAQ About VRTX Stock Insights

What is VRTX current stock price?

What are VRTX stock strengths?

What is VRTX Risk Level?

What is VRTX market cap and volume?

What is VRTX current Stock IQ?

Should I buy VRTX stock right now?

Is VRTX a Strong Buy right now?

What does a 'Strong Buy' rating mean for VRTX?

What does a 'Strong Sell' rating mean for VRTX?

What factors influence VRTX's Stock IQ?

Explore our VRTX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored VRTX Stock Strategies
Effective Risk Management

FIND US ON

Receive our VRTX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

VRTX

Vertex Pharma

Current Price

$419.13

-$16.39 | -3.76%

52W High

$519.68

MKT CAP

$106.63B

52W Low

$362.5

VOL

$783.47K

P/E Ratio

29.49

AVG VOL

$1.34M

RSI

48.58

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

VRTX Rewards

Earnings are forecast to grow

VRTX Rewards

Upgraded on attractively valued

VRTX Rewards

Outperform the market

VRTX Rewards

Investors confidence is positive

VRTX Stock IQ

Login to unlock Vertex Pharma (VRTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$426.27 (-1.67%)

$388.94 (+7.76%)

$441.3 (-5.02%)

$465.73 (-10.01%)

1year

6month

3month

1month

VRTX Analysts Opinion

VRTX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

VRTX Analysts Opinion

VRTX Analysts opinion is positive and also has improved from the past 3 months

VRTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

66%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

25%

92%

VRTX Street Sentiment

VRTX Street Sentiment is bullish and have positive views on the near-term outlook

VRTX Risk Level

VRTX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

VRTX Performance Sentiment

Sentiments overview associated with VRTX events and the stock performance.

66%

20%

Positive

Negative

27 out of 41
events present

8 out of 41
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$437.15

Resistance
Price

$405.58

Current Price Range

$444.70

Show methods +

VRTX Latest Analysis

Stifel Maintains Hold Rating on Vertex (VRTX) Keeps $445 Price Target. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best gene-editing stocks to buy according to hedge funds. On November 10 Stifel maintained a Hold rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). The firm also kept its price target at $445 for the stock. Stifels analysts referenced Vertexs presentation of povetacicept (a dual BAFF/APRIL inhibitor) open-label Phase [….]

Tue Nov 18, 2025

$435.52 | +0.35%

Potential

Goldman Sachs Remains ish on Vertex (VERX) After Q3 2025 Results. Vertex Inc. (NASDAQ:VERX) is included in our list of the overlooked tech stocks to invest in. Vertex Inc. (NASDAQ:VERX) experienced a price target cut on November 5 2025 with Goldman Sachs lowering its target from $43 to $28 while reiterating a Buy rating. The price revision reflects short-term headwinds such as customer bankruptcies and rapid [….]

Mon Nov 17, 2025

$434.02 | -0.72%

Potential

1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November. Key PointsVertexs core business continues to drive strong financial results.

Mon Nov 17, 2025

$434.02 | -0.72%

Earnings

Vertex Resource Group Ltd. Reports Third Quarter 2025 Results. ) - Vertex Resource Group Ltd. (".". or the ".Company".) reports its financial and operational results for the third quarter ended . During the third quarter tariff uncertainties and trade fluctuations persisted maintaining the external pressures that have been the theme throughout the year. In addition customer consolidation further curtailed spending while increasing pricing competitiveness for upcoming projects. Des

Thu Nov 13, 2025

$434.52 | +0.08%

Activity

Potential

V2X INC. ANNOUNCES SALE OF 2.25 MILLION SHARES OF COMMON STOCK IN SECONDARY OFFERING BY VERTEX AEROSPACE. RESTON Va. Nov. 12 2025 /PRNewswire/ -- V2X Inc. (NYSE:VVX) (V2X) a leading provider of global mission solutions announced today the sale of 2.25 million shares of its common stock on an underwritten basis by Vertex Aerospace Holdco LLC (Vertex Aerospace). V2X is not selling any...

Wed Nov 12, 2025

$434.19 | +1.16%

Activity

Vertex Pharmaceuticals Incorporated (VRTX) Presents at UBS Global Healthcare Conference 2025 Transcript.

Tue Nov 11, 2025

$429.22 | +1.93%

Activity

Agree To Buy Vertex Pharmaceuticals At $290 Earn 6.5% Using Options. Investors considering a purchase of Vertex Pharmaceuticals Inc. (Symbol: VRTX) shares but cautious about paying the going market price of $416.38/share might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contrac

Thu Nov 6, 2025

$416.25 | -0.18%

Activity

Potential

Goldman Sachs Maintains Vertex (VERX) Buy Recommendation. Fintel reports that on November 5 2025 Goldman Sachs maintained coverage of Vertex (NasdaqGM:VERX) with a Buy recommendation. Analyst Price Forecast Suggests 89.34% Upside

Thu Nov 6, 2025

$416.25 | -0.18%

Rating

Vertex price target lowered to $24 from $34 at BofA.

Wed Nov 5, 2025

$417.00 | -1.11%

Potential

RBC Capital Maintains Vertex Pharmaceuticals (VRTX) Sector Perform Recommendation. Fintel reports that on November 4 2025 RBC Capital maintained coverage of Vertex Pharmaceuticals (NasdaqGS:VRTX) with a Sector Perform recommendation. Analyst Price Forecast Suggests 16.61% Upside

Wed Nov 5, 2025

$417.00 | -1.11%

Potential

Discover VRTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of VRTX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our VRTX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

VRTX Stock trends

VRTX Stock performance

VRTX Stock analysis

VRTX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing VRTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing VRTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

VRTX Stock Analysis & IQ Rating | Vertex Pharma

VRTX Stock IQ

VRTX Target Price

VRTX Risk Level

VRTX Analysts Opinion

VRTX Street Sentiment

VRTX Performance Sentiment

Technical Price Levels

Explore our VRTX Stock insights

Receive our VRTX Daily Alerts

VRTX Stock IQ

VRTX Street Sentiment

VRTX Risk Level

Technical Price Levels

Discover VRTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of VRTX. We're here to help you make informed investment decisions today.

Receive our VRTX Daily Alerts

VRTX Runner Alarm